NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Verus International, Inc. (Other OTC: VRUS) and Frequency Pharmaceuticals, Inc. (NASDAQ: FREQ). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

By A Silva